Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Hair Relaxer Lawsuits Cleared To Move Forward, After Judge Rejects Motion to Dismiss Master Complaint Judge Rowland said defendants were either premature in seeking dismissal, or that plaintiffs had sufficiently pled their hair relaxer lawsuit claims. November 14, 2023 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all federal hair relaxer lawsuits has rejected efforts by the manufacturers to dismiss thousands of claims that toxic chemicals in the chemical straighteners caused women to develop uterine cancer, ovarian cancer and other injuries. Concerns about the safety of hair relaxers gained widespread attention late last year, following the publication of a study that highlighted a link between use of hair relaxer and uterine cancer in October 2022. Researchers found that that frequent use was associated with a 156% increased risk compared to women who did not use hair relaxers. Women throughout the United States are now pursuing product liability claims against the manufacturers, each indicating that they may have avoided a cancer diagnosis or other injury if the manufacturers had adequately disclosed risks associated with applying the chemicals to their scalps. The makers of Dark & Lovely, Just for Me, ORS Olive Oil, and other widely used hair relaxer products, now face more than 8,200 product liability lawsuits, all raising similar allegations that the manufacturers knew or should have known about link between cancer and hair relaxers, yet placed their desire for profits before the health and safety of African Americans and other women. HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION HAIR RELAXER COMPENSATION Did you or a loved one use hair relaxer products? Uterine cancer, endometrial cancer and ovarian cancer may be caused by chemicals in hair relaxer. See if you are eligible for benefits. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given common questions of fact and law raised in hair relaxer lawsuits filed throughout the federal court system, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established coordinated pretrial proceedings in the Northern District of Illinois under U.S. District Judge Mary Rowland in January 2023. While the litigation continues to grow, Judge Rowland has indicated that she will establish a “bellwether” process, where small groups of representative claims will go through case-specific discovery and be prepared for early trial dates, to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation. Hair Relaxer Lawsuit Motion to Dismiss Denied Early in the litigation, the manufacturers filed a wide-ranging motion to dismiss, claiming that the lawsuits were preempted by federal law, and that plaintiffs had failed to adequately present their claims. In a memorandum opinion and order (PDF) issued on November 13, Judge Rowland rejected most of the defendants’ assertions, allowing the litigation to move forward. On many of the claims, such as failure to warn, design defect, negligence, and punitive damages, Judge Rowland said the defendants’ efforts to have them dismissed were premature, or that plaintiffs had clearly presented their claims correctly. “Defendants contend that Plaintiffs’ allegations are conclusory and they have not identified specific products or defects in those products. The Court does not agree,” Judge Rowland wrote. “Plaintiffs allege that Defendants’ products contained toxic chemicals. Specifically, they allege harmful and carcinogenic ingredients in Defendants’ hair relaxer products ‘are known to disrupt and/or harm a woman’s endocrine system’.” Judge Rowland, however, did dismiss plaintiffs’ fraud claims, saying that their pleading failed to meet the higher legal standard for fraud-related allegations. She also dismissed two international defendants, which the Court did not have jurisdiction over, Dubar International Limited, and Dermovia Skin Essentials, Inc. Plaintiffs Propose November 2025 Bellwether Trial Date The decision means the hair relaxer lawsuits will proceed through the pretrial process, including the preparation of a small group of representative claims for early bellwether trials, which will help the parties gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation. On November 10, plaintiffs proposed a draft hair relaxer lawsuit bellwether trial plan (PDF), which outlines a process for selecting potential bellwether cases and putting them through the discovery process. The plan calls for the first hair relaxer lawsuit bellwether trial to be begin on November 3, 2025, with a second trial starting on February 2, 2026. The plaintiffs’ plan calls for the first bellwether trials to be restricted to those cases involving uterine cancer, endometrial cancer, and/or ovarian cancer injuries filed on or before December 15, 2023. Each party would select 10 initial bellwether discovery cases each, including seven uterine and/or endometrial cancer claims, and three ovarian cancer lawsuits. These 20 cases would be selected by May 1, 2024, and would go through core fact discovery until September 2024, when the parties will choose four bellwether trial cases. If they cannot agree on four such cases, they will each submit their own list and the Court will decide which four will be the first to go before juries by October 4, 2024. The plan also includes proposed summary judgment and Daubert dates, further discovery, and other proposed trial preparation dates. Following coordinated discovery in the MDL and any early bellwether trials, if the parties fail to negotiate hair relaxer settlements for individuals diagnosed with uterine cancer, ovarian cancer, uterine fibroids and other complications, Judge Rowland may later remand each individual lawsuit directly filed in the MDL back to the U.S. District Court where it would have originated for a separate trial. Tags: Endocrine Disruptors, Endometriosis, Hair Relaxer, Hair Straighteners, L'Oreal, Perm, Phthalates, Uterine Cancer, Uterine Fibroids Find Out If You Qualify for Hair Relaxer Compensation More Hair Relaxer Lawsuit Stories Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit March 25, 2025 Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge March 13, 2025 Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports March 5, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)